| Year |
Citation |
Score |
| 2023 |
Kohan AA, Lupien M, Cescon D, Deblois G, Ventura M, Metser U, Veit-Haibach P. Detection of metabolic adaptation in a triple-negative breast cancer animal model with [F]choline-PET imaging as a surrogate for drug resistance. European Journal of Nuclear Medicine and Molecular Imaging. PMID 38095672 DOI: 10.1007/s00259-023-06546-0 |
0.59 |
|
| 2023 |
Cameron S, Deblois G, Hawley JR, Qamra A, Zhou S, Tonekaboni SAM, Murison A, Van Vliet R, Liu J, Locasale JW, Lupien M. Chronic hypoxia favours adoption to a castration-resistant cell state in prostate cancer. Oncogene. PMID 37020039 DOI: 10.1038/s41388-023-02680-z |
0.703 |
|
| 2022 |
Lebeau B, Jangal M, Zhao T, Wong CK, Wong N, Cañedo EC, Hébert S, Aguilar-Mahecha A, Chabot C, Buchanan M, Catterall R, McCaffrey L, Deblois G, Kleinman C, Park M, et al. 3D chromatin remodeling potentiates transcriptional programs driving cell invasion. Proceedings of the National Academy of Sciences of the United States of America. 119: e2203452119. PMID 36037342 DOI: 10.1073/pnas.2203452119 |
0.331 |
|
| 2022 |
Wu Q, Nie DY, Ba-Alawi W, Ji Y, Zhang Z, Cruickshank J, Haight J, Ciamponi FE, Chen J, Duan S, Shen Y, Liu J, Marhon SA, Mehdipour P, Szewczyk MM, ... ... Deblois G, et al. PRMT inhibition induces a viral mimicry response in triple-negative breast cancer. Nature Chemical Biology. PMID 35578032 DOI: 10.1038/s41589-022-01024-4 |
0.676 |
|
| 2021 |
Fukano M, Park M, Deblois G. Metabolic Flexibility Is a Determinant of Breast Cancer Heterogeneity and Progression. Cancers. 13. PMID 34572926 DOI: 10.3390/cancers13184699 |
0.335 |
|
| 2021 |
Cepeda Cañedo E, Totten S, Ahn R, Savage P, MacNeil D, Hudson J, Autexier C, Deblois G, Park M, Witcher M, Ursini-Siegel J. 66ShcA potentiates the cytotoxic response of triple negative breast cancers to PARP inhibitors. Jci Insight. PMID 33470989 DOI: 10.1172/jci.insight.138382 |
0.336 |
|
| 2020 |
Wu Q, Ba-Alawi W, Deblois G, Cruickshank J, Duan S, Lima-Fernandes E, Haight J, Tonekaboni SAM, Fortier AM, Kuasne H, McKee TD, Mahmoud H, Kushida M, Cameron S, Dogan-Artun N, et al. GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer. Nature Communications. 11: 4205. PMID 32826891 DOI: 10.1038/S41467-020-18020-8 |
0.712 |
|
| 2020 |
Deblois G, Madani Tonekaboni SA, Grillo G, Martinez C, Kao YI, Tai F, Ettayebi I, Fortier AM, Savage P, Fedor AN, Liu X, Guilhamon P, Lima-Fernandes E, Murison A, Kuasne H, et al. Epigenetic switch-induced viral mimicry evasion in chemotherapy resistant breast cancer. Cancer Discovery. PMID 32546577 DOI: 10.1158/2159-8290.Cd-19-1493 |
0.754 |
|
| 2020 |
Michealraj KA, Kumar SA, Kim LJY, Cavalli FMG, Przelicki D, Wojcik JB, Delaidelli A, Bajic A, Saulnier O, MacLeod G, Vellanki RN, Vladoiu MC, Guilhamon P, Ong W, Lee JJY, ... ... Deblois G, et al. Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma. Cell. PMID 32445698 DOI: 10.1016/J.Cell.2020.04.047 |
0.732 |
|
| 2019 |
Wu Q, Heidenreich D, Zhou S, Ackloo S, Krämer A, Nakka K, Lima-Fernandes E, Deblois G, Duan S, Vellanki RN, Li F, Vedadi M, Dilworth J, Lupien M, Brennan PE, et al. A chemical toolbox for the study of bromodomains and epigenetic signaling. Nature Communications. 10: 1915. PMID 31015424 DOI: 10.1038/S41467-019-09672-2 |
0.706 |
|
| 2018 |
Casey AE, Sinha A, Singhania R, Livingstone J, Waterhouse P, Tharmapalan P, Cruickshank J, Shehata M, Drysdale E, Fang H, Kim H, Isserlin R, Bailey S, Medina T, Deblois G, et al. Mammary molecular portraits reveal lineage-specific features and progenitor cell vulnerabilities. The Journal of Cell Biology. PMID 29921600 DOI: 10.1083/Jcb.201804042 |
0.724 |
|
| 2017 |
Samuel N, Wilson G, Deblois G, Said BI, Fischer NW, Lemire M, Lou Y, Li W, Alexandrova R, Novokmet A, Tran J, Nichols KE, Finlay JL, Choufani S, Remke M, et al. Abstract NG05: TP53-mediated human cancer susceptibility is defined by epigenetic dysregulation of microRNA-34A Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Ng05 |
0.594 |
|
| 2016 |
Boukhaled GM, Cordeiro B, Deblois G, Dimitrov V, Bailey SD, Holowka T, Domi A, Guak H, Chiu HC, Everts B, Pearce EJ, Lupien M, White JH, Krawczyk CM. The Transcriptional Repressor Polycomb Group Factor 6, PCGF6, Negatively Regulates Dendritic Cell Activation and Promotes Quiescence. Cell Reports. PMID 27498878 DOI: 10.1016/J.Celrep.2016.07.026 |
0.688 |
|
| 2016 |
Deblois G, Smith HW, Tam IS, Gravel SP, Caron M, Savage P, Labbé DP, Bégin LR, Tremblay ML, Park M, Bourque G, St-Pierre J, Muller WJ, Giguère V. ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancer. Nature Communications. 7: 12156. PMID 27402251 DOI: 10.1038/Ncomms12156 |
0.488 |
|
| 2016 |
Samuel N, Wilson G, Said BI, Pan A, Deblois G, Fischer NW, Alexandrova R, Casallo G, Paton T, Lupien M, Gariepy J, Merico D, Hudson TJ, Malkin D. Transcriptome-wide characterization of the endogenous miR-34A-p53 tumor suppressor network. Oncotarget. PMID 27391063 DOI: 10.18632/Oncotarget.10417 |
0.551 |
|
| 2014 |
Perry MC, Dufour CR, Eichner LJ, Tsang DW, Deblois G, Muller WJ, Giguère V. ERBB2 deficiency alters an E2F-1-dependent adaptive stress response and leads to cardiac dysfunction. Molecular and Cellular Biology. 34: 4232-43. PMID 25246633 DOI: 10.1128/Mcb.00895-14 |
0.336 |
|
| 2014 |
Labbé DP, Nowak DG, Deblois G, Lessard L, Giguère V, Trotman LC, Tremblay ML. Prostate cancer genetic-susceptibility locus on chromosome 20q13 is amplified and coupled to androgen receptor-regulation in metastatic tumors. Molecular Cancer Research : McR. 12: 184-9. PMID 24379448 DOI: 10.1158/1541-7786.Mcr-13-0477 |
0.331 |
|
| 2013 |
McGuirk S, Gravel SP, Deblois G, Papadopoli DJ, Faubert B, Wegner A, Hiller K, Avizonis D, Akavia UD, Jones RG, Giguère V, St-Pierre J. PGC-1α supports glutamine metabolism in breast cancer. Cancer & Metabolism. 1: 22. PMID 24304688 DOI: 10.1186/2049-3002-1-22 |
0.441 |
|
| 2013 |
Schade B, Lesurf R, Sanguin-Gendreau V, Bui T, Deblois G, O'Toole SA, Millar EK, Zardawi SJ, Lopez-Knowles E, Sutherland RL, Giguère V, Kahn M, Hallett M, Muller WJ. β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression. Cancer Research. 73: 4474-87. PMID 23720052 DOI: 10.1158/0008-5472.Can-12-3925 |
0.44 |
|
| 2013 |
Deblois G, St-Pierre J, Giguère V. The PGC-1/ERR signaling axis in cancer Oncogene. 32: 3483-3490. PMID 23208510 DOI: 10.1038/Onc.2012.529 |
0.432 |
|
| 2013 |
Deblois G, Giguère V. Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond. Nature Reviews. Cancer. 13: 27-36. PMID 23192231 DOI: 10.1038/Nrc3396 |
0.483 |
|
| 2012 |
Lessard L, Labbé DP, Deblois G, Bégin LR, Hardy S, Mes-Masson AM, Saad F, Trotman LC, Giguère V, Tremblay ML. PTP1B is an androgen receptor-regulated phosphatase that promotes the progression of prostate cancer. Cancer Research. 72: 1529-37. PMID 22282656 DOI: 10.1158/0008-5472.Can-11-2602 |
0.42 |
|
| 2012 |
Deblois G, Giguère V. Cancer: Reprogramming clinical outcome. Nature. 481: 275-6. PMID 22258604 DOI: 10.1038/481275A |
0.438 |
|
| 2011 |
Giguère V, Dufour CR, Eichner LJ, Deblois G, Cermakian N. Estrogen-Related Receptor α, the Molecular Clock, and Transcriptional Control of Metabolic Outputs Cold Spring Harbor Symposia On Quantitative Biology. 76: 57-61. PMID 22179984 DOI: 10.1101/Sqb.2011.76.011031 |
0.33 |
|
| 2011 |
Deblois G, Giguère V. Functional and physiological genomics of estrogen-related receptors (ERRs) in health and disease. Biochimica Et Biophysica Acta. 1812: 1032-40. PMID 21172432 DOI: 10.1016/J.Bbadis.2010.12.009 |
0.34 |
|
| 2010 |
Deblois G, Chahrour G, Perry MC, Sylvain-Drolet G, Muller WJ, Giguère V. Transcriptional control of the ERBB2 amplicon by ERRalpha and PGC-1beta promotes mammary gland tumorigenesis. Cancer Research. 70: 10277-87. PMID 20961995 DOI: 10.1158/0008-5472.Can-10-2840 |
0.426 |
|
| 2010 |
Wilson BJ, Tremblay AM, Deblois G, Sylvain-Drolet G, Giguère V. An acetylation switch modulates the transcriptional activity of estrogen-related receptor alpha. Molecular Endocrinology (Baltimore, Md.). 24: 1349-58. PMID 20484414 DOI: 10.1210/Me.2009-0441 |
0.364 |
|
| 2010 |
Giguère V, Eichner LJ, Deblois G. 4 Control of cancer cell metabolism by nuclear receptor-based transcriptional pathways Ejc Supplements. 8: 1-2. DOI: 10.1016/S1359-6349(10)70813-2 |
0.416 |
|
| 2009 |
Deblois G, Hall JA, Perry MC, Laganière J, Ghahremani M, Park M, Hallett M, Giguère V. Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity. Cancer Research. 69: 6149-57. PMID 19622763 DOI: 10.1158/0008-5472.Can-09-1251 |
0.456 |
|
| 2008 |
Deblois G, Giguère V. Nuclear receptor location analyses in mammalian genomes: from gene regulation to regulatory networks. Molecular Endocrinology (Baltimore, Md.). 22: 1999-2011. PMID 18292239 DOI: 10.1210/Me.2007-0546 |
0.307 |
|
| 2005 |
Laganière J, Deblois G, Lefebvre C, Bataille AR, Robert F, Giguère V. From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proceedings of the National Academy of Sciences of the United States of America. 102: 11651-6. PMID 16087863 DOI: 10.1073/Pnas.0505575102 |
0.458 |
|
| 2005 |
Laganière J, Deblois G, Giguère V. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells. Molecular Endocrinology (Baltimore, Md.). 19: 1584-92. PMID 15831516 DOI: 10.1210/Me.2005-0040 |
0.448 |
|
| 2004 |
Carrier JC, Deblois G, Champigny C, Levy E, Giguère V. Estrogen-related receptor alpha (ERRalpha) is a transcriptional regulator of apolipoprotein A-IV and controls lipid handling in the intestine. The Journal of Biological Chemistry. 279: 52052-8. PMID 15466464 DOI: 10.1074/Jbc.M410337200 |
0.317 |
|
| 2003 |
Laganière J, Deblois G, Giguère V. Nuclear receptor target gene discovery using high-throughput chromatin immunoprecipitation. Methods in Enzymology. 364: 339-50. PMID 14631854 DOI: 10.1016/S0076-6879(03)64019-X |
0.332 |
|
| Show low-probability matches. |